Published in Int J Clin Pract on February 16, 2009
Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study). Cardiovasc Diabetol (2010) 0.90
Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency. Lipids Health Dis (2010) 0.85
Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial. Arch Med Sci (2011) 0.85
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia. Neth Heart J (2011) 0.83
Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients. Lipids Health Dis (2011) 0.81
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes. Lipids Health Dis (2010) 0.76
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial. BMC Res Notes (2012) 0.75
Are there differences in LDL-C target value attainment in Austrian federal states? Yes! Wien Med Wochenschr (2013) 0.75
Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease. J Am Heart Assoc (2015) 0.75
Sleight of hand in trial design: average behaviour is not average, not all new information is really new. Int J Clin Pract (2009) 0.75
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update. Wien Klin Wochenschr (2016) 0.75
Effectiveness of Ezetimibe in Reducing the Estimated Risk for Fatal Cardiovascular Events in Hypercholesterolaemic Patients with Inadequate Lipid Control While on Statin Monotherapy as Measured by the SCORE Model. Adv Prev Med (2010) 0.75
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax (2000) 2.74
Brachial, radial, or femoral approach for elective Palmaz-Schatz stent implantation: a randomized comparison. Cathet Cardiovasc Diagn (1997) 2.63
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study. Int J Clin Pract (2008) 1.50
Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia. Int Angiol (2004) 1.39
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med (1990) 1.32
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study. Int J Obes (Lond) (2010) 1.23
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12
Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem (1997) 1.07
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med (2007) 1.03
Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization. FEBS Lett (1996) 1.01
Comparison of athletes with life-threatening ventricular arrhythmias with two groups of healthy athletes and a group of normal control subjects. Am J Cardiol (1994) 1.00
Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 0.99
Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus. Diabetes Obes Metab (2007) 0.99
The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus. Diabetes Obes Metab (2011) 0.99
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials. Diabetes Obes Metab (2011) 0.97
Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation (1992) 0.96
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol (1999) 0.96
Changes in intracellular localization of calpastatin during calpain activation. Biochem J (1999) 0.95
Tako-tsubo cardiomyopathy with left ventricular outflow tract (LVOT) obstruction: case report and review of the literature. Acta Clin Belg (2011) 0.94
Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and Estonia. J Intern Med (2002) 0.93
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. J Thromb Haemost (2010) 0.92
The effect of alendronate on bone mass after distal forearm fracture. J Bone Miner Res (2000) 0.90
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Int J Clin Pract (2010) 0.89
Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion. Am J Cardiol (1993) 0.88
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia. J Lipid Res (1999) 0.88
Effects of once-daily sitagliptin on 24-h glucose control following 4 weeks of treatment in Japanese patients with type 2 diabetes mellitus. Horm Metab Res (2009) 0.88
Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Eur J Biochem (2000) 0.88
Images in cardiology: Left subclavian artery stenosis presenting as unstable angina pectoris after coronary artery bypass grafting. Heart (2005) 0.87
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease. Int J Clin Pract (2005) 0.87
Acyl-CoA-binding protein is a potent m-calpain activator. J Biol Chem (2000) 0.87
In vivo validation of a fluid dynamics model of mitral valve M-mode echocardiogram. Med Biol Eng Comput (1996) 0.87
Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study. Int J Clin Pract (2008) 0.86
Comparison between ankle and toe index in patients with peripheral arterial disease. Int Angiol (1988) 0.85
Properties of calpastatin forms in rat brain. FEBS Lett (1998) 0.85
Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. Eur Neurol (1999) 0.85
Differential degradation of calpastatin by mu- and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells. FEBS Lett (2000) 0.84
Aortopulmonary artery fistula in atherosclerotic pseudoaneurysm presenting with congestive heart failure after aortic valve replacement. Acta Chir Belg (2006) 0.84
Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. Nutr Metab Cardiovasc Dis (2008) 0.83
Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. Cephalalgia (2006) 0.82
Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients. Haemostasis (1982) 0.82
Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein. Mol Cell Biochem (2001) 0.82
Modulation of rat brain calpastatin efficiency by post-translational modifications. FEBS Lett (1997) 0.82
A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients. Pain (2001) 0.81
Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients. Atherosclerosis (1989) 0.81
Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol (2000) 0.81
Mitral insufficiency with congenital double-orifice mitral valve in an elderly patient. Eur J Echocardiogr (2003) 0.81
Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells. Arterioscler Thromb Vasc Biol (1997) 0.80
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes Obes Metab (2010) 0.80
Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients. Thromb Haemost (1982) 0.79
Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res (2014) 0.79
Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event. Cardiology (2008) 0.79
Obesity and the metabolic syndrome in a student cohort from Southern Italy. Nutr Metab Cardiovasc Dis (2009) 0.78
The renin-angiotensin system in essential hypertension: associations with cardiovascular risk. Blood Press (1999) 0.78
A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studies. Metabolism (1996) 0.78
Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial. Curr Med Res Opin (2006) 0.78
Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease. Int J Clin Pract (2005) 0.78
Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects. Int Angiol (2011) 0.78
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. Headache (2001) 0.78
Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control. Diabetes Res (1989) 0.77
Thrombin-antithrombin III complexes in type II diabetes mellitus. J Diabetes Complications (1992) 0.77
Interrelation between malonyl dialdehyde-dependent modification and cholesterol content in low-density lipoproteins. Bull Exp Biol Med (2010) 0.77
Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: a preliminary report. Nutr Metab Cardiovasc Dis (2008) 0.76
Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend. Acta Clin Belg (2010) 0.76
Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms. Int J Biochem Cell Biol (2001) 0.76
Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia. Thromb Haemost (1995) 0.76
Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncation. Metabolism (1997) 0.76
LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia. Curr Med Res Opin (2005) 0.76
Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. J Hum Hypertens (1998) 0.76
Combined antihypertensive therapy and sexual dysfunction: terra incognita. Cardiology (2013) 0.75
Invasive thymoma with intracaval growth into the right atrium. Ann Thorac Surg (1993) 0.75
Clinical experience with the first 100 ATS heart valve implants. Cardiovasc Surg (1996) 0.75
[Arterial hypertension: current large therapeutic trials]. Therapie (1997) 0.75
[Enzymological and histological changes in experimental cholestasis]. Dtsch Z Verdau Stoffwechselkr (1967) 0.75
Ventricular arrhythmias in hypertensive patients with mild metabolic alterations. Minerva Cardioangiol (2003) 0.75
The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome. Diabetes Obes Metab (2013) 0.75
Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome. Kidney Int (1999) 0.75
[Myocardial ischemia detected by Holter monitoring: analysis of therapeutical trials realised in stable angina]. Therapie (1995) 0.75
Transesophageal echography as an emergency diagnostic tool for acute aortic dissection. J Thorac Cardiovasc Surg (1993) 0.75
Lessons from ONTARGET. Acta Clin Belg (2008) 0.75
Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene. J Lipid Res (1999) 0.75
Rapid screening of the LDL receptor point mutation FH-Genoa/Palermo. Mutation in brief no. 238. Online. Hum Mutat (1999) 0.75
Independent double sided cardiac thrombosis causing simultaneous systemic and pulmonary embolism. Eur Heart J (1997) 0.75
The incidence of residuals of infectious hepatitis. Rev Int Hepatol (1969) 0.75
[Intermittent claudication of the legs: what can be obtained without pharmacologic agents]. Angiologia (1991) 0.75
Renovascular hypertension associated with neurofibromatosis: a case report. Acta Clin Belg (2007) 0.75